TBC1D2B is a TBC-domain RAB-GTPase-activating protein (RABGAP) that operates on early endosomes to control endocytic membrane trafficking and the fate of internalized cargo (PMID:32623794, PMID:39051763). It is recruited to early endosomes by the small GTPases RAB31 and RAB22A, where it inactivates RAB7A; this RAB7A inactivation blocks fusion of multivesicular endosomes with lysosomes, instead routing intraluminal vesicles toward exosome secretion and diverting EGFR away from lysosomal degradation toward surface recycling and incorporation into microvesicles (PMID:32958903, PMID:39051763). TBC1D2B was originally identified as a RAB22-binding protein, with the RAB interaction occurring through a domain distinct from its catalytic GAP domain (PMID:20070612). Consistent with an early-endocytic role, it colocalizes with RAB5-positive early endosomes and is required for efficient EGF internalization (PMID:32623794). Beyond trafficking, TBC1D2B suppresses E-cadherin internalization, and its transcriptional silencing by the ZEB1/NuRD complex promotes cancer cell invasion and metastasis in non-small-cell lung cancer (PMID:31719531). It also participates in autophagy initiation through a functional LC3-interacting region that binds LC3/GABARAP and ATG12 conjugation complexes, is itself turned over by autophagy, and forms phase-separated condensates upon autophagy induction (PMID:38226533).